Lusheng Wei

1.3k total citations
16 papers, 906 citations indexed

About

Lusheng Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lusheng Wei has authored 16 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Lusheng Wei's work include Pancreatic and Hepatic Oncology Research (7 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). Lusheng Wei is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). Lusheng Wei collaborates with scholars based in China, United States and Sweden. Lusheng Wei's co-authors include Guolin Li, Shangyou Zheng, Huilin Ye, Qing Lin, Quanbo Zhou, Zhihua Li, Yimin Liu, Zhiqiang Fu, Rufu Chen and Rufu Chen and has published in prestigious journals such as Cancer Cell, Cancer Research and Cancer Letters.

In The Last Decade

Lusheng Wei

16 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lusheng Wei China 11 553 469 377 208 67 16 906
Leilei Tao China 11 407 0.7× 306 0.7× 358 0.9× 158 0.8× 51 0.8× 18 765
Qiqiao Du China 13 435 0.8× 385 0.8× 213 0.6× 139 0.7× 46 0.7× 29 757
Tony Bou Kheir United Kingdom 7 727 1.3× 595 1.3× 351 0.9× 84 0.4× 70 1.0× 7 973
Cecilia Monge United States 8 355 0.6× 220 0.5× 393 1.0× 128 0.6× 78 1.2× 30 745
Yanhua Xuan China 18 539 1.0× 221 0.5× 381 1.0× 111 0.5× 80 1.2× 47 884
Dacheng Xie China 20 843 1.5× 492 1.0× 349 0.9× 98 0.5× 106 1.6× 26 1.2k
Wenting Liao China 7 662 1.2× 461 1.0× 305 0.8× 104 0.5× 21 0.3× 9 851
Chu‐Bin Luo China 15 510 0.9× 451 1.0× 295 0.8× 242 1.2× 181 2.7× 26 972
Tianhong Su China 15 418 0.8× 269 0.6× 171 0.5× 112 0.5× 65 1.0× 22 748
Jin Zhu China 12 863 1.6× 734 1.6× 209 0.6× 78 0.4× 89 1.3× 19 1.1k

Countries citing papers authored by Lusheng Wei

Since Specialization
Citations

This map shows the geographic impact of Lusheng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lusheng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lusheng Wei more than expected).

Fields of papers citing papers by Lusheng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lusheng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lusheng Wei. The network helps show where Lusheng Wei may publish in the future.

Co-authorship network of co-authors of Lusheng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lusheng Wei. A scholar is included among the top collaborators of Lusheng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lusheng Wei. Lusheng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Minmin, Kang Chen, Min Yu, et al.. (2025). Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell. 43(9). 1656–1676.e10. 9 indexed citations
2.
Hong, Weifeng, Lusheng Wei, Zhentao Song, et al.. (2024). Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Drug Resistance Updates. 76. 101115–101115. 10 indexed citations
3.
Deng, Junge, Jialiang Zhang, Kaijing Liu, et al.. (2021). N6 -methyladenosine–Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression. Cancer Research. 81(20). 5268–5283. 69 indexed citations
5.
Zhou, Yu, Lusheng Wei, Qing Lin, et al.. (2021). A novel anastomosis technique facilitates pancreaticojejunostomy in total laparoscopic pancreaticoduodenectomy (with video). Langenbeck s Archives of Surgery. 406(8). 2891–2897. 6 indexed citations
6.
Ye, Ying, Jialiang Zhang, Kaiyu Zhu, et al.. (2021). Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Genome Medicine. 13(1). 183–183. 17 indexed citations
7.
Wei, Lusheng, Huilin Ye, Guolin Li, et al.. (2021). Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Cell Death and Disease. 12(3). 232–232. 90 indexed citations
8.
Zhou, Quanbo, Zhiguo Li, Huilin Ye, et al.. (2019). Intraoperative Radiotherapy for Borderline Resectable Pancreatic Cancer: A Retrospective Analysis. 4(1). 1 indexed citations
9.
Zhang, Bin, Huilin Ye, Shangyou Zheng, et al.. (2019). Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer. Cancer Letters. 459. 204–215. 56 indexed citations
10.
Wei, Lusheng, Huilin Ye, Guolin Li, et al.. (2018). Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Cell Death and Disease. 9(11). 1065–1065. 134 indexed citations
11.
Ye, Huilin, Quanbo Zhou, Shangyou Zheng, et al.. (2018). Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Cell Death and Disease. 9(5). 453–453. 175 indexed citations
12.
Cheng, Di, Junge Deng, Bin Zhang, et al.. (2018). LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 36. 159–170. 133 indexed citations
13.
Ye, Huilin, Quanbo Zhou, Shangyou Zheng, et al.. (2018). FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Cell Death and Disease. 9(2). 34–34. 50 indexed citations
14.
Wei, Lusheng, et al.. (2018). The Regulation of Mesenchymal Stem Cell Therapy Through Magnetic Resonance Imaging Agents-Based Cellular Condition and Oxygen Environment. Journal of Biomedical Nanotechnology. 14(11). 1906–1920. 6 indexed citations
15.
Li, Wenzhu, Changhao Chen, Xiaohui Zhao, et al.. (2017). HIF‐2α regulates non‐canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine. 21(11). 2896–2908. 28 indexed citations
16.
Fu, Zhiqiang, Guolin Li, Zhihua Li, et al.. (2017). Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discovery. 3(1). 17004–17004. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026